• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Pen Injectors Devices, Drugs, Combination Products - Product Image

Pen Injectors Devices, Drugs, Combination Products

  • ID: 2493139
  • March 2013
  • Greystone Associates
Already the Dominant Method for Key Biologicals, the Availability of Pen Injectors is Becoming Essential for Several Therapeutic Segments

User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes. Advances in synthetic materials and concurrent development partnerships between pen designers and drug developers are important factors in the growth of this segment. With product evaluations, industry data and forecasts, pen injector company profiles, and detailed analysis of design and economic factors, this report has been organized and written to provide pharmaceutical professionals, drug delivery market participants, and healthcare organizations with all of the information necessary to understand the growing importance of pen injectors on drug development and delivery.

Highlights

- Provides detailed analysis of pen injector market segments, market dynamics and market demographics

- Analyzes therapeutic demand drivers and evaluates commercial pen injector products in eleven major therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues

- Charts product data, market share, and forecasts to 2018

- Profiles injectable drug and device participants, their pen injector product development activities, business strategies, and corporate alliances and affiliations

Already the Dominant Method for Key Biologicals, the Availability of Pen Injectors is Becoming Essential for Several Therapeutic Segments

Executive Summary

Injectable Drug Sector Market Dynamics

The Injectable Drug Ecosystem
Drug Classes, Indications and Demand
What's Driving the Growth in Pen Injectors
Biological Drugs Proliferating
Growth of Self-Administration
Shifting Demographics
Device Design Innovation
Competitive Landscape
Risk Factors

Pen Injector Design Selection Factors

Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Variable vs Fixed Dosing
Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors

Important Pen-Delivered Drug Classes

Anticholonergics
Dopamine Receptors
Hematopoietics
Human Growth Hormone
Immune Modulators
Insulins and Antihyperglycemics
Parathyroid Hormone
Reproductive Hormones
Serotonin Antagonists
Sympathomimetics

Pen Injectors - Therapeutic Sector Assessment

Anemia
Inflammatory Autoimmune Diseases
Diabetes
Emergency Medicine
Hepatitis
Hormone Replacement
Multiple Sclerosis
Osteoporosis
Reproductive Health
Other Commercial Pen Markets & Products

Market Factors

Regulatory Considerations
Patient Preferences and Compliance
Managed Care Initiatives
Private Labeling

Pen Injectors - Company Profiles

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos